U.S. markets close in 27 minutes
  • S&P 500

    -41.73 (-0.99%)
  • Dow 30

    -438.51 (-1.30%)
  • Nasdaq

    -109.27 (-0.77%)
  • Russell 2000

    -52.28 (-2.29%)
  • Crude Oil

    +0.68 (+0.96%)
  • Gold

    -2.80 (-0.16%)
  • Silver

    +0.10 (+0.38%)

    -0.0033 (-0.27%)
  • 10-Yr Bond

    -0.0610 (-4.04%)

    -0.0109 (-0.79%)

    -0.1100 (-0.10%)

    -2,280.94 (-6.03%)
  • CMC Crypto 200

    -61.38 (-6.53%)
  • FTSE 100

    -135.96 (-1.90%)
  • Nikkei 225

    -54.25 (-0.19%)

Zacks Industry Outlook Highlights: CYH, HCA, UHS and THC

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·6 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

For Immediate Release

Chicago, IL – September 24, 2020 – Today, Zacks Equity Research discusses the Medical - Hospital, including Community Health Systems, Inc. CYH, HCA Healthcare, Inc. HCA, Universal Health Services, Inc. UHS and Tenet Healthcare Corp. THC.

Industry: Medical - Hospital

Link: https://www.zacks.com/stock/news/1062517/uhs-or-thc-which-is-a-betterpositioned-stock-right-now

The Zacks Medical - Hospital industry faced disruption due to the COVID-19-led pandemic. However, they are slowly limping back to normalcy by resuming surgeries and other healthcare services.

The hospital industry suffered heavily due to the COVID-19-induced business loss. Cancellation in elective surgeries to make room for coronavirus-infected patients hurt the company’s revenues. The companies also withdrew their respective guidance due to the current market situation. Most companies halted share buybacks in order to preserve cash amid these uncertain economic times.

Nevertheless, the hospitals are well-poised for growth on the back of sustainable balance sheets, accretive mergers and acquisitions, divestitures to pay off debt, favorable cash flow generation, telemedicine services, increased demand for products and services, etc. Some are even trying to curb costs through regulation of variable cost structure, reduction in discretionary spending, temporary salary cuts, furloughing of employees and so on.

Companies have been investing heavily in telehealth, which got ample response amid the COVID-19 environment. For instance, Community Health Systems, Inc. made the most of the rise in adoption of telehealth medicines. In the second quarter, it managed to deliver more than 230,000 Telehealth visits. HCA Healthcare, Inc. also expanded its telemedicine product offerings. In the second quarter, it performed more than 500,000 telemedicine visits.

The overall bullish scenario makes us upbeat about consistent growth in this industry, which should boost prospects of the companies with strong business fundamentals.

Against this backdrop, let’s look at the two leading hospital companies, namely Universal Health Services, Inc. and Tenet Healthcare Corp. with their respective market capitalization of $9 billion and $2.5 billion. Each stock currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

In the past six months, Universal Health and Tenet Healthcare have gained 36.2% and 58.8%, respectively. The industry has rallied 40.9% in the same time frame compared with the S&P 500 composite’s rise of 36%.

Let's analyze certain other parameters to find out which company is better placed.

Earnings Surprise History

A stock’s earnings surprise track helps investors get a fair enough idea about its performance in the previous quarters.

Tenet Healthcare’s bottom line managed to beat estimates in three of the trailing four quarters (while missing the mark in one), the average surprise being 191.4%. Notably, Universal Health’s earnings surpassed the consensus mark in two of the trailing four quarters (while lagging estimates on two occasions), the average beat being 106.3%.

While both companies have an average positive earnings surprise, Tenet Healthcare has an edge over Universal Health here.

Return on Equity

Return on equity is a profitability measure, which accounts for profits generated on shareholders’ equity. Hence, higher ROE reflects the company’s efficiency in utilizing its shareholders’ funds and is preferred by all equity investors.

Tenet Healthcare’s ROE of 82.4% compares favorably with Universal Health’s ROE of 14.8%.


Price-to-EBITDA value is one of the multiples used for valuing hospital companies. Comparing with the industry’s trailing 12 month’s P/EBITDA ratio of 3.07, Tenet Healthcare and Universal Health have a reading of 0.9 and 5.3 each.

It is clear that here Tenet Healthcare’s valuation is better than Universal Health.

Earnings Guidance

Earnings growth along with stock price appreciation is often indicative of a company’s strong potential.

The Zacks Consensus Estimate for Universal Health’s 2020 earnings implies a 5.8% decrease from the year-ago reported figure while the same for Tenet Healthcare suggests an increase of 48.1% from the prior-year reported number.

Tenet Healthcare is a visible winner here.

Debt to Capital

Universal Health’s leverage ratio of 38X betters Tenet Healthcare’s ratio of 96.2X. Therefore, Universal Health is at an advantage over Tenet Healthcare on this front.

Bottom Line

Our comparative analysis shows that Tenet Healthcare is better-placed than Universal Health with respect to its earnings surprise, ROE, valuation and earnings guidance. Meanwhile, Universal Health scores higher in terms of leverage ratio. As the scale is slightly tilted toward Tenet Healthcare, the stock discernibly makes a more promising investment proposition.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339



Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Universal Health Services, Inc. (UHS) : Free Stock Analysis Report
Community Health Systems, Inc. (CYH) : Free Stock Analysis Report
Tenet Healthcare Corporation (THC) : Free Stock Analysis Report
HCA Healthcare, Inc. (HCA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research